| Entry |
|
|---|
| Name |
Mofebutazone (INN);
Monazone (TN)
|
|---|
| Formula |
C13H16N2O2
|
|---|
| Exact mass |
232.1212
|
|---|
| Mol weight |
232.2783
|
|---|
| Structure |
     |
|---|
| Activity |
Analgesic;
Antiinflammatory;
Antipyretic
|
|---|
| Remark |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AA Butylpyrazolidines
M01AA02 Mofebutazone
D07262 Mofebutazone (INN)
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02AA Antiinflammatory preparations, non-steroids for topical use
M02AA02 Mofebutazone
D07262 Mofebutazone (INN)
 |
|---|
| Other DBs |
CAS: 2210-63-1 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 17
1 N1x N 25.4800 -18.4800
2 N1y N 25.4800 -17.0800
3 C5x C 26.8100 -16.6600
4 C1y C 27.6500 -17.7800
5 C5x C 26.8100 -18.9000
6 C1b C 29.0500 -17.7800
7 C1b C 29.7500 -16.5900
8 C1b C 31.1500 -16.5900
9 C1a C 31.8500 -15.4000
10 O5x O 27.2300 -15.3300
11 O5x O 27.2300 -20.2300
12 C8y C 24.3508 -16.2524
13 C8x C 24.3570 -14.8400
14 C8x C 23.1470 -14.1359
15 C8x C 21.9321 -14.8317
16 C8x C 21.9273 -16.2450
17 C8x C 23.1373 -16.9492
BOND 18
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 4 6 1
7 6 7 1
8 7 8 1
9 8 9 1
10 3 10 2
11 5 11 2
12 2 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
|
|---|
